top of page

"Impact of Economic Situation and Policy on the Pricing of Reimbursed Medicines" - new INNOWO report

The press conference has just concluded, during which the president of INNOWO, Agnieszka Sznyk, PhD, along with Prof. Ewelina Nojszewska (SGH Warsaw School of Economics), presented the latest economic data on the decline in prices of reimbursed drugs and the current costs of pharmaceutical production. They also discussed the anticipated consequences of the current policy on the pricing of reimbursed medicines.

They participated in a debate where members of the board of the Polish Pharmaceutical Industry Employers' Association (Polski Związek Pracodawców Przemysłu Farmaceutycznego) - National Drug Manufacturers shared insights into the most significant challenges currently faced by pharmaceutical companies in Poland and the prospects for industry development.


In the coming days, we will share the key findings from this report, developed in collaboration with PZPPF. However, you can already familiarize yourself with its content.


Sytuacja ekonomiczna a kondycja przemysłu farmaceutycznego 01.02.23 update
.pdf
Download PDF • 2.21MB



Comments


bottom of page